Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Tvax Biomedical Inc.
DescriptionImmunotherapy consisting of a cancer vaccine followed by autologous T cell therapy
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationRenal cancer
Indication DetailsTreat stage IV renal cell carcinoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today